Literature DB >> 22648700

Quality-improvement guidelines for hepatic transarterial chemoembolization.

Antonio Basile1, Gianpaolo Carrafiello, Anna Maria Ierardi, Dimitrios Tsetis, Elias Brountzos.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22648700     DOI： 10.1007/s00270-012-0423-z

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN： 0174-1551            Impact factor:   2.740


× No keyword cloud information.
  22 in total

1.  Hepatic Arterial Embolization Using Cone Beam CT with Tumor Feeding Vessel Detection Software: Impact on Hepatocellular Carcinoma Response.

Authors:  F H Cornelis; A Borgheresi; E N Petre; E Santos; S B Solomon; K Brown
Journal:  Cardiovasc Intervent Radiol       Date:  2017-08-02       Impact factor: 2.740

2.  Lipiodol injections for optimization of target volume delineation in a patient with a second tumor of the oropharynx: A case report.

Authors:  Marlen Haderlein; Ricarda Merten; Andrea Stojanovic; Stefan Speer; Claudia Scherl; Rainer Fietkau; Oliver J Ott
Journal:  Strahlenther Onkol       Date:  2015-06-04       Impact factor: 3.621

Review 3.  Chemoembolization of hepatocellular carcinoma with HepaSphere™.

Authors:  Katerina Malagari; Anastasia Pomoni; Dimitrios Filippiadis; Dimitrios Kelekis
Journal:  Hepat Oncol       Date:  2015-05-05

4.  TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib.

Authors:  Roberto Iezzi; Maurizio Pompili; Emanuele Rinninella; Eleonora Annicchiarico; Matteo Garcovich; Lucia Cerrito; Francesca Ponziani; AnnaMaria De Gaetano; Massimo Siciliano; Michele Basso; Maria Assunta Zocco; GianLodovico Rapaccini; Alessandro Posa; Francesca Carchesio; Marco Biolato; Felice Giuliante; Antonio Gasbarrini; Riccardo Manfredi
Journal:  Eur Radiol       Date:  2018-08-31       Impact factor: 5.315

Review 5.  Clinical Pharmacokinetics and Pharmacodynamics of Transarterial Chemoembolization and Targeted Therapies in Hepatocellular Carcinoma.

Authors:  Anne Hulin; Jeanick Stocco; Mohamed Bouattour
Journal:  Clin Pharmacokinet       Date:  2019-08       Impact factor: 6.447

6.  Posterior reversible leukoencephalopathy syndrome secondary to hepatic transarterial chemoembolization with doxorubicin drug eluting beads.

Authors:  C Andrew Kistler; Joseph Caleb McCall; Saad Sultan Ghumman; Ijlal Akbar Ali; Ali A Siddiqui
Journal:  J Gastrointest Oncol       Date:  2014-04

7.  Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment.

Authors:  Pi-Yi Chang; Chun-Chieh Huang; Chao-Hung Hung; Chih-Yung Yu; Ding-Kwo Wu; Jen-I Hwang; Po-Chin Liang; Reng-Hong Wu; Wei-Lun Tsai; Yih-Jyh Lin; Yi-Sheng Liu; Huei-Lung Liang; Rheun-Chuan Lee; Chien-Hung Chen
Journal:  Liver Cancer       Date:  2018-03-29       Impact factor: 11.740

Review 8.  New advances in hepatocellular carcinoma.

Authors:  Sonia Pascual; Iván Herrera; Javier Irurzun
Journal:  World J Hepatol       Date:  2016-03-28

9.  Comparison of Chemoembolization, Radioembolization, and Transarterial Ethanol Ablation for Huge Hepatocellular Carcinoma (≥ 10 cm) in Tumour Response and Long-Term Survival Outcome.

Authors:  Simon Chun Ho Yu; Joyce Wai-Yi Hui; Leung Li; Carmen Chi-Min Cho; Edwin Pun Hui; Stephen Lam Chan; Winnie Ming-Ming Yeo
Journal:  Cardiovasc Intervent Radiol       Date:  2021-10-03       Impact factor: 2.740

Review 10.  Arterial Therapies of Non-Colorectal Liver Metastases.

Authors:  Gilbert Puippe; Thomas Pfammatter; Niklaus Schaefer
Journal:  Viszeralmedizin       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.